Select Page

Press Releases

Sign up to get full access to all our latest Press Releases

Rapid Dose Therapeutics Commences Clinical Research Trial with GI Research Institute and University of British Columbia

August 20, 2019


Burlington, ON, August 20, 2019 — Rapid Dose Therapeutics Corp. (CSE: DOSE), (“RDT”) announced today the commencement of a clinical research trial with the GI Research Institute (“GIRI”) and the University of British Columbia (“UBC”) under the direction of Dr. Brian L. Bressler, MD, as...

Rapid Dose Therapeutics and Thrive Cannabis Sign Manufacturing Agreement for Quickstrip™ Cannabis Products

August 8, 2019


Burlington, ON, Brantford, ON, August 8, 2019 — Rapid Dose Therapeutics Corp. (CSE: DOSE), (“RDT”) announced today that they have signed a Manufacturing Agreement (“the Agreement”) with Thrive Cannabis (“Thrive”) to produce QuickStrip™ cannabis products for both the Canadian medical and recreational markets.  This Agreement...

Rapid Dose Therapeutics Expands Agreement for Quickstrip™ Nutraceutical Product Line in Eastern Europe and Increases Purchase Order to US$4.0 Million

August 1, 2019


Burlington, ON, August 1,  2019 — Rapid Dose Therapeutics Corp. (CSE: DOSE), (“RDT”) announced today that they have signed an amendment to the 12 month distribution  agreement (the “Agreement”) with Ukraine Pharma to expand the marketing and distribution of QuickStrip™ nutraceutical products to seven additional...

Rapid Dose Reports First Quarter Fiscal 2020 Financial Results and Provides Operations Update

July 30, 2019


BURLINGTON, Ontario – July 30, 2019 – Rapid Dose Therapeutics Corp. (“RDT”) (CSE: DOSE) today reported its financial results for the first quarter of fiscal 2020, which ended on May 31, 2019. “This quarter represents a very exciting milestone for RDT as we commence the...

Rapid Dose Therapeutics Completes Quickstrip™ Equipment Installation at Flower One Resulting in Immediate Revenue Generation

July 25, 2019


BURLINGTON, Ontario – July 25, 2019 – Rapid Dose Therapeutics Corp. (“RDT”) (CSE: DOSE) announced today that they have completed the last phase of the Managed Strip Services Agreement (the “Agreement”) signed in January 2019 with Flower One Holdings Inc. (“Flower One”) (CSE: FONE) (OTCQX:...

Rapid Dose Therapeutics Signs Distribution Agreement for Quickstrip™ Nutraceutical Product Line and Receives US$2.1 Million Purchase Order

July 16, 2019


Burlington, ON, July 16, 2019 — Rapid Dose Therapeutics Corp. (CSE: DOSE), (“RDT”) and Ukraine Pharma (the “Company”) announced today that they have signed a twelve month distribution  agreement (the “Agreement”) to export QuickStrip™ nutraceutical products to Ukraine and a number of other Eastern European...

Rapid Dose Therapeutics and Chemesis to Introduce Innovative Quickstrip™ Oral Thin Strips to the Michigan Cannabis Market

June 27, 2019


Burlington, ON and Vancouver, BC, June 27, 2019 — Rapid Dose Therapeutics Corp. (CSE: DOSE), (“RDT”) and Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company”) announced today that they have expanded the scope of their previously announced agreement (the “Agreement”) expanding the...

Rapid Dose Therapeutics Announces Commercialization of Quickstrip™ Oral Thin Strips

June 13, 2019


Licensee, Chemesis International Inc., begins efforts for distribution of QuickStrip™ across United States & Puerto Rico BURLINGTON, Ontario – June 13, 2019 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient...

Rapid Dose Therapeutics Appoints Vice President, Research & Innovation

June 6, 2019


BURLINGTON, Ontario – June 6, 2019 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian leader in drug delivery solutions,  is pleased to announce that Dr. Rina Carlini has been appointed Vice President, Research & Innovation. Dr. Carlini is an accomplished...

Rapid Dose Therapeutics and TFB & Associates Ltd. Sign Agreement for the Sale and Distribution of Innovative Quickstrip™ Nutraceutical Product Line Across Canada

April 16, 2019


BURLINGTON, Ontario – April 16, 2019 – Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian life sciences company focused on innovative drug and active ingredient delivery solutions, is pleased to announce it has signed a Distribution Agreement with TFB & Associates...

1 2 3 4 5 6